Colorado GLP-1 insurance law in 2027: what SB25-048 requires
By John Samaras, price analyst · Prices checked Nov 16, 2026
From January 1, 2027, large group health plans issued or renewed in Colorado must cover obesity treatment: a diabetes prevention program, medical nutrition therapy, intensive behavioral therapy and bariatric surgery. The law does not make them cover GLP-1s. It makes carriers offer the policyholder the option to buy anti-obesity drug coverage that includes at least one GLP-1.
What it costs without insurance
If your plan says no
Eden$99 a monthIncludes medication, provider review and shippingCheck price →
Collective$59 a month, drug priceLowest price on our chartCheck price →
Who this affects
People in a large group health plan issued or renewed in Colorado. The section names large group plans only. Whether the drugs are covered depends on whether the policyholder, usually the employer, buys the option.
When it starts
The governor signed the act on June 3, 2025. It takes effect on January 1, 2027.
If you lose coverage: cash now
Two cash programs to check.
No insurance needed.
Prices checked Nov 16, 2026.
- Eden$99 a monthIncludes medication, provider review and shippingcompounded semaglutidecompounded tirzepatide $129 a monthCheck price →Eden's GLP-1 page, then an online assessment
- Check price →
- Compounded semaglutide and tirzepatide prices, from $59 a month
- Find your GLP-1 program in four questions
What the signed act says
a carrier shall offer the policyholder the option to purchase coverage for FDA-approved anti-obesity medications, including at least one FDA-approved GLP-1 medication.
- The required treatment covers a program like the national diabetes prevention program, medical nutrition therapy, intensive behavioral or lifestyle therapy and metabolic and bariatric surgery.
- The act says a carrier does not have to offer coverage for which premiums would not cover expected benefits.
- It defines a GLP-1 medication as an FDA-approved GLP-1 receptor agonist with an indication for regulating blood sugar levels and appetite.
- The insurance commissioner may adopt rules to carry out the section.
Sources:
- Colorado General Assembly, SB25-048 Diabetes Prevention and Obesity Treatment Act, dated June 3, 2025, read November 15, 2026.
- Colorado General Assembly, SB25-048 signed act, dated June 3, 2025, read November 15, 2026 from the Internet Archive copy.
What to do before January 1
- Ask HR whether your employer bought the optional anti-obesity drug coverage for its 2027 plan.
- If it did not, the required obesity care still applies, and the cash routes on this page cover the drug.
- Check your plan papers for the renewal date, since the rule applies to plans issued or renewed from January 1, 2027.
Employers changing GLP-1 coverage in 2027. 2027 open enrollment dates.
What cash costs today
Compounded semaglutide and tirzepatide are pharmacy-made versions that are not Wegovy, Ozempic, Zepbound or Mounjaro.
Compounded prices are the monthly drug price at the lowest-priced program. Any membership is listed on that program's own page.
| Cash route | Monthly price | Checked |
|---|---|---|
| Compounded semaglutide | From $59 | November 16, 2026 |
| Compounded tirzepatide | From $69 | November 16, 2026 |
| Wegovy pill from NovoCare | From $149 at the 1.5mg starter dose | November 16, 2026 |
| Zepbound vial from LillyDirect | From $299 at 2.5mg | November 16, 2026 |
Buying cash in late November? GLP-1 Black Friday and Cyber Monday offers shows each program's 30-day low and high.
Frequently asked questions
Does Colorado require insurance to cover GLP-1s in 2027?
Who decides whether my Colorado plan covers Wegovy or Zepbound?
Does SB25-048 apply to marketplace plans?
Cash does not go through your plan and does not count toward its deductible. Federal plan GLP-1 changes for 2027. GLP-1 coverage by payer.